Hematology

Latest News

Video Series

Back to the Bench: Exploring the Potential of CAR T-Cell Therapy in Oncology

The Future of CAR T-Cell Therapy in LBCL

The Impact of Real-World Analyses in the Utilization of CAR T-Cell Therapy in LBCL

Expert Perspective on Real-World Follow-Up Analyses of Liso-Cel in LBCL

Bridging Therapy With CAR T-Cell Therapy in LBCL

Real World Findings for Liso-Cel in LBCL From the Cell Therapy Consortium

Understanding Malignancy Risks With the Use of CAR T-cell Therapies

CAR T-Cell Therapy as a Second-Line Treatment for LBCL

Sequencing With CAR T-Cell Therapy for LBCL

The Expanding Utility of CAR T-Cell Therapy in LBCL

Latest Videos

Robin E. Miller, MD, the director of the Sickle Cell Disease Program at Nemours Children’s Hospital

Robin E. Miller, MD, on Integrating Gene Therapy into Clinical Care for Sickle Cell Disease

Steven W. Pipe, MD, a professor of pediatric hematology/oncology at the University of Michigan Health

Steven W. Pipe, MD, on Integrating Gene Therapy into Clinical Care for Hemophilia B

Interview Highlights From ASH's 2025 Meeting

Steven W. Pipe, MD, on the Implications of the Final Data From Hemgenix’s HOPE-B Trial

Rabi Hanna, MD, the chairman of the Division of Pediatric Hematology & Oncology and BMT at Cleveland Clinic Children's

Rabi Hanna, MD, on Practical Considerations for Integrating Gene Therapy

Steven W. Pipe, MD, on the End-of-Study Results From Hemgenix’s HOPE-B Trial

Rabi Hanna, MD, on Evaluating Gene Editing Therapy Reni-Cel for Severe Sickle Cell Disease

Deevyashali Parekh, MBBS, an internal medicine resident at SUNY Upstate Medical University Hospital

Deevyashali Parekh, MBBS, on Evaluating CAR-T in Patients With Multiple Myeloma and Renal Failure

Janna Minehart, MD, a clinical fellow in hematology oncology (Master of Science Translational Research Program) at the University of Pennsylvania

Janna Minehart, MD, on Hematology-Oncology Immunotherapy Highlights at ASH 2025

Crawford Strunk, MD, an associate staff member at the Cleveland Clinic and the codirector of the Sickle Cell Medical Neighborhood

Crawford Strunk, MD, on Integrating Gene Therapy into Clinical Care for Sickle Cell Disease

Shorts

0:47

The potential of bringing hemophilia B gene therapy to younger patients

3 months ago

0:41

The need for more data for sickle cell gene therapy

3 months ago

0:42

Interdisciplinary collaboration in cell and gene therapy

3 months ago

0:48

The Reality of Gene Therapy for Sickle Cell Disease

3 months ago

0:30

How Families Choose Between SCD Therapies

3 months ago

0:47

The Importance of Nonmyeloablative Chemotherapy to Cell Therapy

9 months ago

Michael T. Lotze, MD

Podcasts

April 3, 2026

ImmunoLogic, Episode 9: "Rewiring Immunotherapy for High-Risk Neuroblastoma" With Kristopher R. Bosse, MD

February 10, 2026

ImmunoLogic, Episode 8: "Surgery Meets Immunotherapy: A One-Two Punch for Breast Cancer" With Julia C. Tchou, MD, PhD, FACS

January 2, 2026

ImmunoLogic, Bonus Episode: "Chemo Optional, Data Mandatory - A Year-End Recap"

December 24, 2025

ImmunoLogic, Bonus Episode: "ASH 2025: Practice-Changers on the Ground and on the Wi‑Fi"

December 2, 2025

ImmunoLogic, Episode 7: "Turbocharging CAR T-Cells: The IL-9 Orthogonal Signal" With Anusha Kalbasi, MD

November 4, 2025

Quarter Century Update: The Impact of Artificial Intelligence

October 31, 2025

Quarter Century Update: Thoughts on Reducing Costs of Goods

October 30, 2025

Quarter Century Update: Future Predictions for the Field

October 29, 2025

Quarter Century Update: What Does the Field Need Most Right Now?

October 29, 2025

Quarter Century Update: What Lessons Should Guide the Next Generation of Developers and Regulators?

CME Content

Virtual Event

Wyoming State Oncology Society

2 Sessions are Available!

Virtual Event

Tennessee Oncology Practice Society

1 Session is Available!

Virtual Event

North Carolina Oncology Association

2 Sessions are Available!

Virtual Event

Oncology Town Hall: Insights Reshaping How We Treat MPNs From the 2026 Summer Oncology Meetings

June 29, 2026

Video

Cases and Conversations: Applying the Evidence – Real-World Strategies to Optimize Care for Patients With Myelofibrosis

Ruben A. Mesa, MD, FACP; Andrew Kuykendall, MD; Sangeetha Venugopal, MD, MS

Video

Cases and Conversations: Adopting New Treatment Strategies in Polycythemia Vera and Essential Thrombocythemia

Gabriela Hobbs, MD; Rami Komrokji, MD; Douglas A. Tremblay, MD

$(CME Track) Community Oncology Connections™: Leveraging Recent Advances in the Treatment of Relapsed/Refractory Follicular Lymphoma – Arkansas$

Video

(CME Track) Community Oncology Connections™: Leveraging Recent Advances in the Treatment of Relapsed/Refractory Follicular Lymphoma – Arkansas

Lori A. Leslie, MD; Alex Mejia, MD

In-Person + Virtual Event

10th Annual Live Medical Crossfire®: Hematologic Malignancies

July 11-12, 2026

Video

Medical Crossfire®: Harnessing the Power of Modern Therapies in Newly Diagnosed Multiple Myeloma

C. Ola Landgren, MD, PhD; Mohamad Mohty, MD, PhD; Surbhi Sidana, MD

$Cases and Conversations™: Sorting Through the Expanding Treatment Options for Patients with Relapsed/Refractory Multiple Myeloma$

Video

Cases and Conversations™: Sorting Through the Expanding Treatment Options for Patients with Relapsed/Refractory Multiple Myeloma

C. Ola Landgren, MD, PhD; Mohamad Mohty, MD, PhD; Surbhi Sidana, MD

Video

Medical Crossfire®: Improving Patient Outcomes in Myeloproliferative Neoplasms With Novel Therapeutic Approaches

Rami Komrokji, MD; Gabriela Hobbs, MD; John Mascarenhas, MD; Naveen Pemmaraju, MD

Video

Cases & Conversations™: Transforming AML Care—Precision Strategies, Evolving Therapies, and Clinical Insights

Gail J. Roboz, MD; Hagop Kantarjian, MD; Catherine Lai, MD, MPH; Amer Zeidan, MBBS, MHS

Virtual Event

A Community-Based Roadmap to CAR-T Therapy: Optimizing Delivery and Outcomes

4-Part Webinar Series

Virtual Event

Kentucky Society of Clinical Oncology

2 Sessions are Available!

Video

Expert Perspectives on Applying Recent Evidence to Practice in the Management of Newly Diagnosed Multiple Myeloma

Amrita Krishnan, MD; Meletios Athanasios (Thanos) C. Dimopoulos, MD; Shaji Kumar, MD; Katja Weisel, MD

Virtual Event

Empire State Hematology & Oncology Society (New York)

3 Sessions are Available!

Multimedia

Imaging Matters: Decoding PSMA PET for Better Decision-Making

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Scott T. Tagawa, MD, MS, FACP, FASCO

$(CPE Track) Community Oncology Connections™: Leveraging Recent Advances in the Treatment of Relapsed/Refractory Follicular Lymphoma – Arkansas$

Video

(CPE Track) Community Oncology Connections™: Leveraging Recent Advances in the Treatment of Relapsed/Refractory Follicular Lymphoma – Arkansas

Lori A. Leslie, MD; Alex Mejia, MD

Case-based Simulation

SimulatEd™: Partnering for Precision – A Framework for Personalized Care Planning in Acute Lymphoblastic Leukemia

Jae Park, MD

Video

9th Annual School of Nursing Oncology™

Beth Faiman, PhD, MSN, APN-BC, BMTCN, AOCN, FAAN, FAPO; Beth Sandy, MSN, CRNP, FAPO; Lindsay Adkins, MSN, FNP-BC, BMTCN; Jeneth Aquino, DNP, FNP-BC; Casey Gormley, MSN, FNP-C, AOCNP; Heather J. Jackson, PhD, FNP-BC; Kelsey Martin, AG-ACNP-BC, AOCNP; Nerina T. McDonald, PA-C; Lauren Verity Moore, DNP, MSN, AGACNP-BC; Faith A. Mutale, DNP, CRNP; Tiffany Richards, PhD, ANP-BC, AOCNP; Emily Skotte, DNP, MSN, ACNP-BC; Leslie Smith, DNP, RN, APRN-CNS, AOCNS, BMTCN; Saneese Stephen, PA-C, MPAS; Sara M. Tinsley-Vance, PhD, APRN, AOCN

More News

Around the Helix: Cell and Gene Therapy Company Updates – April 22, 2026

ByNoah Stansfield

April 22nd 2026

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – April 15, 2026

ByNoah Stansfield

April 15th 2026

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – April 8, 2026

ByNoah Stansfield

April 8th 2026

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – April 1, 2026

ByNoah Stansfield

April 1st 2026

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – March 25, 2026

ByNoah Stansfield

March 25th 2026

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – March 18, 2026

ByNoah Stansfield

March 18th 2026

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – March 11, 2026

ByNoah Stansfield

March 11th 2026

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – March 4, 2026

ByNoah Stansfield

March 4th 2026

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Practical Considerations for Implementing SCD Gene Therapy Into Clinical Use

ByRobin E. Miller, MD,Noah Stansfield

March 4th 2026

Robin E. Miller, MD, director of the Sickle Cell Disease Program at Nemours Children’s Hospital, discussed what clinics need in order to start administering gene therapy effectively.

Around the Helix: Cell and Gene Therapy Company Updates – February 25, 2026

ByNoah Stansfield

February 25th 2026

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – February 18, 2026

ByNoah Stansfield

February 18th 2026

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

CGTLive®’s Weekly Rewind – February 13, 2026

ByNoah Stansfield

February 13th 2026

Review top news and interview highlights from the week ending February 13, 2026.

Around the Helix: Cell and Gene Therapy Company Updates – February 11, 2026

ByNoah Stansfield

February 11th 2026

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – February 4, 2026

ByNoah Stansfield

February 4th 2026

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

CGTLive®’s Weekly Rewind – January 30, 2026

ByNoah Stansfield

January 30th 2026

Review top news and interview highlights from the week ending January 30, 2026.

Around the Helix: Cell and Gene Therapy Company Updates – January 28, 2026

ByNoah Stansfield

January 28th 2026

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Integrating Gene Therapy into Clinical Care for Hemophilia B

BySteven W. Pipe, MD,Noah Stansfield

January 27th 2026

Steven W. Pipe, MD, a professor of pediatric hematology/oncology at the University of Michigan Health, also discussed open questions that remain for the future of the hemophilia B gene therapy.

CGTLive®’s Weekly Rewind – January 23, 2026

ByNoah Stansfield

January 23rd 2026

Review top news and interview highlights from the week ending January 23, 2026.

Jeffrey Goldberg, MD, PhD, a professor and chair of ophthalmology at the Byers Eye Institute at Stanford University

Jeffrey Goldberg, MD, PhD, on the Potential of Cell and Gene Therapy in Glaucoma

ByJeffrey Goldberg, MD, PhD,Noah Stansfield

January 22nd 2026

For Glaucoma Awareness Month, CGTLive® interviewed the chair of ophthalmology at the Byers Eye Institute at Stanford University about the potential of cell and gene therapy for the condition.